An observational study in Postoperative Delirium and Heart Valve Diseases, sponsored by Osman Sila Aydin. Not yet recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-05.
Sponsored by Osman Sila Aydin · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 92 studies in Emergence Delirium with a site in Turkey — 28 open to participants now, 32 under way, none of them phase 3. Emergence Delirium · Turkey.
Among the 92 studies in Emergence Delirium with a site in Turkey, this one is the 20th largest by planned enrollment of the 51 observational ones that give a count, is one of 28 that started in 2026, is one of 51 observational ones, reaches primary completion later than 28 of the 31 other live ones, and was the 86th registered.
753 studies on the registry are indexed under Emergence Delirium; 261 are open to participants now.
Browse Emergence Delirium studies →28 of the 92 studies in Emergence Delirium with a site in Turkey are open now. Recruiting first, the newest first:
Ankara City Hospital Bilkent · Sites in Turkey
Ages 60+ · Healthy volunteers
Elazıg Fethi Sekin Sehir Hastanesi · Sites in Turkey
Ages 65–80 · Women only
Sehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital · Sites in Turkey
Ages 65+
Sakarya University · Sites in Turkey
Ages 6–12
Fatma Cigdem Ozakin · Sites in Turkey
Ages 65+
A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →
Of the 141 Emergence Delirium studies recruiting now, 78 (55%) set no upper age limit and 43 (30%) stop at 75 or younger; 33 take children under 18; 24 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
92 studies; the count open now beside each. This study's row is marked.
First in 2012; this study’s year is marked. 28 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 120 is below the median of 164 across 278 observational studies indexed under Emergence Delirium.
Median enrollment 80 across the 41 interventional studies, 110 across the 51 observational. Of the 52 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 92 has an industry lead sponsor. The 10 most frequent:
Osman Sila Aydin is the lead sponsor of 2 studies on the registry; 2 are open to participants now.
Osman Sila Aydin has 1 study filed under Emergence Delirium — fewer than ten, so there is no comparison to draw.
10 of the studies in Emergence Delirium with a site in Turkey that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07604337seher orbay yasliPre-emptive Local Anesthesia and Emergence Behavior After Pediatric Dental General Anesthesia | 2026-12 |
| NCT07552259TC Erciyes UniversityEffect of Preoperative Fasting Duration on Postoperative Pain and Emergence Agitation in Pediatric Patients Undergoing Urogenital Surgery | 2026-12-10 |
| NCT07800845Konya City HospitalRemifentanil vs Fentanyl in Children 7-12 After Urologic Surgery: Emergence Delirium and Recovery Quality | 2026-12-15 |
| NCT07877285Elazıg Fethi Sekin Sehir HastanesiImmunonutrition and Neuromonitoring for Postoperative Delirium in Gynecologic Oncology | 2027-01-01 |
| NCT07860996Sehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research HospitalTotal Intravenous Versus Inhalational Anesthesia in Patients Undergoing Hip Fracture Surgery | 2027-03-30 |
Add all 10 to your calendar (.ics) → With an account.
Among the 92 studies in Emergence Delirium with a site in Turkey, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Postoperative delirium is a frequent complication after cardiac surgery. This prospective observational study will evaluate whether cerebral blood flow velocity measured by transcranial Doppler before and during elective heart valve surgery is associated with delirium during the first five postoperative days. Bispectral index, near-infrared spectroscopy, and arterial blood gas data will also be recorded. Delirium will be assessed daily by an independent evaluator who is blinded to the intraoperative measurements and artificial intelligence predictions, using CAM-ICU for mechanically ventilated patients or the Turkish 3D-CAM for patients on the ward.
The study will also compare zero-shot delirium risk predictions from five general-purpose large language models (Claude, GPT, Gemini, Grok, and Kimi) with the blinded clinical assessments. The models will not be trained on data from the study cohort.
This is a single-center, prospective observational cohort study of 120 adults undergoing elective heart valve surgery under general anesthesia. All participants will receive the institution's standard anesthesia and analgesia protocol. No treatment will be assigned by the study.
Cerebral monitoring will include bispectral index (BIS), near-infrared spectroscopy (NIRS), and intermittent transcranial Doppler (TCD) measurements. TCD measurements will be obtained preoperatively at baseline (T0), at initiation of cardiopulmonary bypass (T1), during bypass (T2), during removal of the aortic cross-clamp (T3), and at separation from bypass (T4). Arterial blood gas parameters will be recorded at these time points and postoperatively, including a postoperative measurement and a measurement at 6 hours. The Standardized Mini-Mental State Examination will be administered preoperatively only to exclude participants with substantial baseline cognitive impairment; it will not be analyzed as an outcome.
The primary hypothesis is that a lower preoperative absolute mean middle cerebral artery blood flow velocity is associated with postoperative delirium. Exploratory analyses will assess whether intraoperative mean flow velocity normalized to baseline is associated with delirium in the direction of either hypoperfusion or hyperperfusion.
Postoperative delirium will be assessed daily on postoperative days 1 through 5 by an independent blinded evaluator using CAM-ICU in mechanically ventilated patients or the Turkish 3D-CAM in ward patients. Blinding will be maintained by separating the perioperative data and artificial intelligence prediction team, the delirium assessment team, and the statistician who merges the locked datasets for analysis.
Five general-purpose large language models will generate independent zero-shot delirium risk predictions for each participant using a standardized prompt and fixed recorded model versions. Predictions will be time-stamped and locked before the outcome data are merged. Model performance will be evaluated against the blinded reference standard using sensitivity, specificity, area under the receiver operating characteristic curve, and calibration. The primary clinical association will be analyzed using logistic regression, and model discrimination will be compared using the DeLong test.
Adults scheduled for elective heart valve surgery at University of Health Sciences Bursa Yuksek Ihtisas Training and Research Hospital who meet the eligibility criteria.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.
A “mini-stroke”: temporary stroke-like symptoms caused by reduced blood flow to part of the brain, spinal cord or eye, without signs of a new stroke on a scan.
Stroke symptoms need emergency care at once, even if they go away.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
MMSE and MoCA
Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
TIA (transient ischaemic attack)
A “mini-stroke”: temporary stroke-like symptoms caused by reduced blood flow to part of the brain, spinal cord or eye, without signs of a new stroke on a scan.
Stroke symptoms need emergency care at once, even if they go away.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Adults undergoing elective heart valve surgery under general anesthesia with the institution's standard anesthesia and analgesia protocol. BIS, NIRS, transcranial Doppler, and arterial blood gas measurements are recorded before and during surgery, followed by blinded postoperative delirium assessment on postoperative days 1 through 5.
Incidence of Postoperative Delirium
Postoperative delirium will be assessed once daily by an independent evaluator blinded to the intraoperative measurements and artificial intelligence predictions. CAM-ICU will be used for mechanically ventilated patients and the Turkish 3D-CAM will be used for patients on the ward. The participant-level outcome is the occurrence of at least one positive delirium assessment during the assessment period.
Time frame: Postoperative days 1 through 5
Association Between Baseline Middle Cerebral Artery Flow Velocity and Postoperative Delirium
Bilateral mean middle cerebral artery flow velocity will be measured preoperatively by transcranial Doppler in centimeters per second. The association between lower baseline flow velocity and the occurrence of postoperative delirium will be evaluated using logistic regression.
Time frame: Preoperative baseline through postoperative day 5
Association Between Intraoperative Relative Middle Cerebral Artery Flow Velocity and Postoperative Delirium
Mean middle cerebral artery flow velocity measured at the intraoperative TCD time points will be expressed as a percentage of the participant's preoperative baseline value. Exploratory analyses will evaluate whether relative hypoperfusion or hyperperfusion is associated with postoperative delirium.
Time frame: Intraoperative period through postoperative day 5
Predictive Performance of General-Purpose Large Language Models for Postoperative Delirium
Each of five fixed, recorded general-purpose large language model versions will generate an independent zero-shot delirium risk prediction using standardized perioperative data. Predictions will be locked before merging with the blinded reference outcome. Performance will be summarized using sensitivity, specificity, area under the receiver operating characteristic curve, and calibration; discrimination will be compared using the DeLong test.
Time frame: Perioperative prediction through postoperative day 5 reference assessment
Plan to share: No — Individual participant data sharing is not planned.
Start is estimated for Oct 2026; primary completion for Aug 2027, 10 months later.
Of 180 non-industry observational studies under Emergence Delirium, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 43. This study's planned 10 months is below that.
Counting every sponsor, half of 180 studies reached it within 21 months; a quarter within 10 and three quarters within 43.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is not yet recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Osman Sila Aydin